Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2000
12/26/2000US6165774 Culturing virus in cells, separating out virus, solubilizing hemagglutinin-neuramidase and fusion envelope glycoproteins from virus, and coisolating and copurifying using ion exchange chromatography and hydroxyapatite matrix
12/26/2000US6165771 Compounds
12/26/2000US6165767 Protein phosphatase-related molecules
12/26/2000US6165766 Amino acid sequence of serine/threonine protein kinase; anticarcinogenic/antiarthritic/antiinflammatory agents; treatment of osteoporosis, adult respiratory disease syndrome, inflammatory bowel disease, eating disorders; diagnosis
12/26/2000US6165762 Amino acid sequence of enzyme; drug screening of bactericides and bacteriostats; vaccines; diagnosis of infections
12/26/2000US6165759 Amino acid sequence; diagnosis, prophylaxis and therapy of infections; vaccines; bacteriostats; bactericides; screening of enzyme inhibitors and activators
12/26/2000US6165752 Expression system which produces polypeptide of defined amino acid sequence when present in a cell; diagnosis and therapy for creutzfeldt-jakob disease and nervous system disorders; anticarcinogenic agents
12/26/2000US6165751 HLDAT86 polynucleotides
12/26/2000US6165748 Useful in the modulation of cellular formation, growth, differentiation, proliferation and/or maintenance of a variety of adult and embryonic tissues and organs
12/26/2000US6165745 Recombinant production of immunoglobulin-like domains in prokaryotic cells
12/26/2000US6165731 Drug screening of modulators of polypeptide subunit of a skp1p/cullin/f-box ubiquitin ligase complex by using ubiquitination system and comparing ubiquitination of enzyme substrate with or without test compound
12/26/2000US6165730 Amino acid sequences of epitopes; for immunoassay diagnosis and immunogens for vaccines
12/26/2000US6165478 DNA encoding Chlamydia pneumoniae antigenic polypeptide
12/26/2000US6165477 Mature recombinantly produced protein from eucaryotic cells which is protective against dengue infection, which raises antibodies useful in passive immunization, and which is useful in diagnosis of infection by the virus.
12/26/2000US6165472 Folyl-polyglutamate synthetase (fpgs) of s. pnuemoniae is necessary for a fully functional folate synthesis pathway. having a present benefit of being useful to screen compounds for antibiotic activity.
12/26/2000US6165466 Antagonists of interleukin-15
12/26/2000US6165465 Immunologic enhancement of the somatogenic effect of somatotropin with an antibody
12/26/2000US6165464 Monoclonal antibodies directed to the HER2 receptor
12/26/2000US6165462 Sugar kinase
12/26/2000US6165461 Tao protein kinases and methods of use therefor
12/26/2000US6165460 Generation of immune responses to prostate-specific antigen (PSA)
12/21/2000WO2000077486A2 Compositions and methods for detecting treponema pallidum
12/21/2000WO2000077256A1 48 human secreted proteins
12/21/2000WO2000077255A1 49 human secreted proteins
12/21/2000WO2000077237A1 49 human secreted proteins
12/21/2000WO2000077226A1 22025, a novel human cyclic nucleotide phosphodiesterase
12/21/2000WO2000077210A1 Equine granulocyte-macrophage colony-stimulating factor (gm-csf)
12/21/2000WO2000077208A2 Gustatory receptors in drosophila
12/21/2000WO2000077207A2 Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto
12/21/2000WO2000077206A2 The myostatin gene promoter and inhibition of activation thereof
12/21/2000WO2000077199A1 Cloning and expression of a novel 5-ht4 receptor
12/21/2000WO2000077198A2 Identification and molecular characterisation of proteins, expressed in the tick salivary glands
12/21/2000WO2000077197A1 47 human secreted proteins
12/21/2000WO2000077191A1 Tumor necrosis factor related receptor, tr6
12/21/2000WO2000077179A2 Human poly(adp-ribose) polymerase 2 materials and methods
12/21/2000WO2000077178A1 IMMUNOLOGICAL CONTROL OF β-AMYLOID LEVELS IN VIVO
12/21/2000WO2000077173A1 42 human secreted proteins
12/21/2000WO2000077168A2 ANTAGONISTS OF BMP AND TGFβ SIGNALLING PATHWAYS
12/21/2000WO2000077166A2 Gene expression modulated in gastrointestinal inflammation
12/21/2000WO2000077049A1 Antifucoidan antibody
12/21/2000WO2000077044A1 Use of soluble protein molecules expressed by the pancreas and kidney glomerulus
12/21/2000WO2000077041A2 Peptides from decorin binding protein and their uses
12/21/2000WO2000077040A2 Human intracellular signaling molecules
12/21/2000WO2000077037A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/21/2000WO2000077035A2 Novel potassium channels and genes encoding these potassium channels
12/21/2000WO2000077026A1 49 human secreted proteins
12/21/2000WO2000077023A1 48 human secreted proteins
12/21/2000WO2000077022A1 50 human secreted proteins
12/21/2000WO2000077021A1 48 human secreted proteins
12/21/2000WO2000076587A1 Antibody-based treatment for streptococcus pneumoniae infection
12/21/2000WO2000076542A1 Use of antibodies against cd20 for the treatment of the graft versus host disease
12/21/2000WO2000076540A2 Streptococcus pneumoniae proteins and vaccines
12/21/2000WO2000076534A1 Manufacturing method for intravenous immune globulin and resultant product
12/21/2000WO2000076531A1 47 human secreted proteins
12/21/2000WO2000076530A1 49 human secreted proteins
12/21/2000WO2000076319A1 Vaccine formulations and methods for immunizing an individual against shed antigen-specific b cells
12/21/2000WO2000076310A1 Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions
12/21/2000WO2000066736B1 Growth factor homolog zvegf4
12/21/2000WO2000053752A3 Promotion or inhibition of angiogenesis and cardiovascularization
12/21/2000WO2000053628A3 Genes encoding human potassium channel proteins
12/21/2000WO2000052056A3 Anti-plasmodium compositions and methods of use
12/21/2000WO2000050596A3 14273 receptor, a novel g-protein coupled receptor
12/21/2000WO2000050062A3 Methods and compositions for altering mucus secretion
12/21/2000WO2000048631A3 Adjuvant and cell maturation agent
12/21/2000WO2000047762A3 Enriched central nervous system cell populations
12/21/2000WO2000046240A3 Polypeptides involved in immune response
12/21/2000WO2000042068A3 Hiv related peptides
12/21/2000WO2000035950A3 Reagents and methods useful for detecting diseases of the breast
12/21/2000WO2000020041A8 Removal of preexisting antibodies to enhance the effectiveness of a therapeutic viral immunogenic agent
12/21/2000EP1144671A3 Enriched central nervous system cell populations
12/21/2000DE19944995C1 Detecting irreversible damage to IgG antibodies comprises determining their ability to block aggregation of cells by an antibody directed against the ligand binding site of Fc gamma receptor RII or RIII
12/21/2000DE19927306A1 New mesenchymal stem cell antigen, used to raise antibodies for e.g. cell characterization and bone marrow typing
12/21/2000DE19925739A1 Therapeutikum mit einem Botulinum-Neurotoxin Agent with a botulinum neurotoxin
12/21/2000CA2751621A1 Hybridomas that undergo class-switching in vitro
12/21/2000CA2391364A1 47 human secreted proteins
12/21/2000CA2391361A1 47 human secreted proteins
12/21/2000CA2390946A1 49 human secreted proteins
12/21/2000CA2387696A1 48 human secreted proteins
12/21/2000CA2383048A1 49 human secreted proteins
12/21/2000CA2383041A1 49 human secreted proteins
12/21/2000CA2382769A1 42 human secreted proteins
12/21/2000CA2382748A1 50 human secreted proteins
12/21/2000CA2382743A1 48 human secreted proteins
12/21/2000CA2382735A1 49 human secreted proteins
12/21/2000CA2382185A1 48 human secreted proteins
12/21/2000CA2377431A1 Antibody-based treatment for streptococcus pneumoniae infection
12/21/2000CA2376717A1 Human poly(adp-ribose) polymerase 2 materials and methods
12/21/2000CA2376693A1 Immunological control of .beta.-amyloid levels in vivo
12/21/2000CA2376675A1 Antagonists of bmp and tgf.beta. signalling pathways
12/21/2000CA2376667A1 Gene expression modulated in gastrointestinal inflammation
12/21/2000CA2376421A1 Identification and molecular characterisation of proteins, expressed in the tick salivary glands
12/21/2000CA2376389A1 Cloning and expression of a novel 5-ht4 receptor
12/21/2000CA2376288A1 Use of antibodies against cd20 for the treatment of the graft versus host disease
12/21/2000CA2376243A1 Gustatory receptors in drosophila
12/21/2000CA2375924A1 Compositions and methods for detecting treponema pallidum
12/21/2000CA2375619A1 Equine granulocyte-macrophage colony-stimulating factor (gm-csf)
12/21/2000CA2375560A1 Manufacturing method for intravenous immune globulin and resultant product
12/21/2000CA2374909A1 Human intracellular signaling molecules
12/21/2000CA2374000A1 Use of soluble protein molecules expressed by the pancreas and kidney glomerulus
12/20/2000EP1060260A2 Elongation factor-2 kinase (ef-2 kinase) and methods of use therefor
1 ... 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 ... 1494